Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOTEM: Truvada switch impact on lipids
NCT00323492Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Started Sep 2005; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00323492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323492.